Dermal Filler Global Market Report 2022

Major players in the dermal filler market are Allergan Inc., Anika Therapeutics Inc., BioPlus Co. Ltd., Bioxis Pharmaceuticals, Dr. Korman Laboratories Ltd., Galderma S.A., Medy Tox Inc, Merz Pharma GmbH & Co. KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics Inc., Scivision Biotech Inc, Sculpt Fillers, Sinclair Pharma, Suneva Medical Inc., and Teoxane Laboratories.

The global dermal fillers market is expected to grow from $4.83 billion in 2021 to $5.41 billion in 2022 at a compound annual growth rate (CAGR) of 12%. The dermal fillers market is expected to grow to $7.61 billion in 2026 at a CAGR of 8.9%.

The dermal filler market consists of sales of dermal fillers by entities (organizations, sole traders, and partnerships) that are used to restore facial volume and diminish facial lines. Dermal fillers are gel-like substances that are also called soft tissue fillers and are designed to be injected beneath the surface of the skin.

The main types of dermal fillers are calcium hydroxylapatite, hyaluronic acid, poly-alkylimide, polylactic acid, polymethylmethacrylate microspheres.Calcium Hydroxylapatite dermal fillers are used in moderate-to-severe creases such as nasolabial folds, marionette lines, and frown lines to enhance the fullness of the cheeks and other facial contours.

The different products include biodegradable, and non-biodegradable and are used in various applications such as scar treatment, wrinkle correction treatment, lip enhancement, and restoration of volume or fullness. It is employed by numerous end users, including hospitals, cosmetic clinics, outpatient centers, beauty centers, and others.

North America was the largest region in the dermal filler market in 2021.Asia Pacific is expected to be the fastest-growing region in the forecast period.

The regions covered in the dermal filler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The dermal fillers market research report is one of a series of new reports that provides dermal filler market statistics, including dermal filler industry global market size, regional shares, competitors with a dermal filler market share, detailed dermal filler market segments, market trends and opportunities, and any further data you may need to thrive in the dermal filler industry. This dermal filler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

An increasing number of aesthetic procedures performed by plastic surgeons is expected to drive the growth of the dermal filler market going forward.Aesthetic procedures refer to procedures that improve the face and body appearance.

There has been a growing emphasis on the body and beauty for identity and self-expression.Dermal fillers are used majorly in plastic surgery or aesthetic procedures to help create a smoother and fuller appearance on the face.

For instance, according to the American Society for Aesthetic Plastic Surgery, in 2021, facial procedures increased by 54% and aesthetic body procedures shot up by 63% from 2020. Therefore, the increasing number of aesthetic procedures performed by plastic surgeons propels the growth of the dermal filler market.

Technological advancements have emerged as the key trend gaining popularity in the dermal filler market.Companies operating in the dermal filler market are focusing on developing innovative products for market growth.

For instance, in April 2021, Sinclair Pharma, a UK-based pharmaceutical company, launched MaiLi, a new hyaluronic acid filler that harnesses the power of OxiFree HA technology for the treatment of medium-sized skin depressions, fine-lines, the periorbital area, and is effective for lip enhancement. MaiLi uses 24% less product for the same volumizing effect.

In October 2020, Allergan Aesthetics, an AbbVie Company, a US-based pharmaceutical company, acquired Luminera’s dermal fillers business for an undisclosed amount.The acquisition is expected to enhance Allergan Aesthetics’ leading dermal filler portfolio with its JUV DERM collection of fillers along with the innovative technology.

Luminera is an Israel-based company that manufactures dermal filler products.

The countries covered in the dermal filler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.